Literature DB >> 16776750

Relative androgen deficiency in relation to obesity and metabolic status in older men.

R Y T Chen1, G A Wittert, G R Andrews.   

Abstract

BACKGROUND: Although androgen deficiency in men has been linked with obesity and the metabolic syndrome, whether it predisposes to, or is a consequence of, type 2 diabetes mellitus (T2DM) is still unclear.
OBJECTIVE: To determine the relationship between plasma androgen levels, obesity, metabolic status and T2DM in men of 70 years or older. DESIGN AND METHODS: A sample of 195 men from the Australian Longitudinal Study of Ageing with a mean age of 76.2 +/- 0.3 years were followed up for 8 years. Total testosterone (TT), fasting plasma glucose (FPG), urate, serum creatinine, total cholesterol (TC), HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), triglycerides (TG), blood pressure (BP), body mass index (BMI), waist circumference (WC) and diabetic status were assessed at baseline. Self-reported diabetic status was obtained after 8 years. Metabolic syndrome was diagnosed based on the Third National Cholesterol Education Program Adult Treatment Panel clinical criteria.
RESULTS: TT levels were lower in diabetic men compared with non-diabetic men (12.1 +/- 0.7 vs. 14.2 +/- 0.4 nmol/l, p = 0.026). TT levels in healthy, non-diabetic men over 80 years of age were lower (11.9 +/- 0.8 vs. 15.0 +/- 0.5 nmol/l, p = 0.002) than TT levels in those aged 70-79 years, inversely related to BMI (r = -0.26, p = 0.001), WC (r = -0.30, p < 0.001) and TG (r = -0.22, p = 0.005) and positively related to LDL-C (r = 0.25, p = 0.002). Men with the metabolic syndrome had significantly lower levels of TT and HDL-C, and higher values of BP, FPG, TG, BMI and WC, compared with those without. However, no significant difference in plasma TT levels was noted between men with incident T2Dm and healthy men. Stepwise linear regression analysis revealed that only LDL-C and WC related significantly to the variance of TT. Multiple logistic regression revealed FPG to be the only independent predictor of incident diabetes (odds ratio = 60.2, p = 0.003).
CONCLUSIONS: Testosterone levels continue to decline even in healthy men over the age of 80 years. Although TT levels were inversely related to visceral obesity and several components of the metabolic syndrome, our data do not support a predictive or causative role for decreasing TT levels in the development of incident T2Dm. Androgen deficiency is consequent upon, rather than a cause of, poor metabolic status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16776750     DOI: 10.1111/j.1463-1326.2005.00532.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  10 in total

Review 1.  Management of obesity in the elderly: too much and too late?

Authors:  R L Kennedy; U Malabu; M Kazi; V Shahsidhar
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

3.  Bioactive androgens and glucuronidated androgen metabolites are associated with subcutaneous and ectopic skeletal muscle adiposity among older black men.

Authors:  Iva Miljkovic; Jane A Cauley; Amy S Dressen; Christopher L Gordon; Bret H Goodpaster; Lewis H Kuller; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Eric S Orwoll; Joseph M Zmuda
Journal:  Metabolism       Date:  2011-02-25       Impact factor: 8.694

Review 4.  Obesity, type 2 diabetes, and testosterone in ageing men.

Authors:  Gary Wittert; Mathis Grossmann
Journal:  Rev Endocr Metab Disord       Date:  2022-07-14       Impact factor: 9.306

5.  Androgenicity and venous endothelial function in post-menopausal women.

Authors:  M A Maturana; M C Rubira; F Consolim-Colombo; M C Irigoyen; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

6.  Is bilateral orchiectomy for metastatic prostate cancer treatment associated with high cardiovascular risk?

Authors:  Konstantinos Stamatiou; Eleni Stamatopoulou; George Christopoulos
Journal:  Aging Dis       Date:  2013-10-07       Impact factor: 6.745

Review 7.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

8.  A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus.

Authors:  Pankaj Kumar Agarwal; Parminder Singh; Subhankar Chowdhury; S K Sharma; Anirban Majumdar; Parag Shah; Rakesh Sahay; S Vageesh Ayyar; Hemant Phatale; Chandar M Batra; Raeesuddin Syed; Pradeep Shetty
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

Review 9.  Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Xiang Cai; Ye Tian; Tao Wu; Chen-Xi Cao; Hong Li; Kun-Jie Wang
Journal:  Asian J Androl       Date:  2014 Jan-Feb       Impact factor: 3.285

10.  Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies.

Authors:  Judith S Brand; Maroeska M Rovers; Bu B Yeap; Harald J Schneider; Tomi-Pekka Tuomainen; Robin Haring; Giovanni Corona; Altan Onat; Marcello Maggio; Claude Bouchard; Peter C Y Tong; Richard Y T Chen; Masahiro Akishita; Jourik A Gietema; Marie-Hélène Gannagé-Yared; Anna-Lena Undén; Aarno Hautanen; Nicolai P Goncharov; Philip Kumanov; S A Paul Chubb; Osvaldo P Almeida; Hans-Ulrich Wittchen; Jens Klotsche; Henri Wallaschofski; Henry Völzke; Jussi Kauhanen; Jukka T Salonen; Luigi Ferrucci; Yvonne T van der Schouw
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.